Strategies to improve decision-making in early drug development will be under the spotlight on November 4th 2004 when one of the industry’s leading early phase specialists hosts a web-based discussion and presentation.
The on-line sessions have been designed by Pharmaceutical Profiles (Nottingham, UK) to provide an informative and thought-provoking overview to help highlight the key challenges facing the pharmaceutical industry and examine innovative solutions to typical problems.
It is the company’s second major webinar. The first was ‘attended’ on-line by more than 60 key industry delegates and was delivered by Professor Ian Wilding, a frequent speaker at international meetings and a respected authority on drug delivery and intestinal absorption. He will also deliver the second webinar.
The presentation will include an overview of the current drug development process and whether it is in need of real innovation, Phase 0 PK/ADME studies and the benefits of utilising microdosing technologies, employing microdosing investigations to increase productivity in early drug development, human drug absorption studies as a ‘route map’ for product development and choosing the correct enabling technologies using human drug absorption investigations.
Anyone wishing to sign up to the webinar can do so at: http://invite.mshow.com/findshow.aspx?usertype=0&cobrand=100&shownumber=187305
Professor Wilding, Chairman of Pharmaceutical Profiles, served as an expert scientist for the FDA in the area of Food Effects on Drug Bioavailability and is currently the only European scientist working with PQRI (an FDA/AAPS initiative) examining US regulatory guidance in the area of Oral Biopharmaceutics. He is a frequent speaker at international meetings and is a respected authority on drug delivery and intestinal absorption.
Professor Wilding is also on the Advisory Board for the University of Nottingham Institute of Enterprise & Innovation and is a member of the steering committee for the East Midlands MediLink programme, designed to improve connectivity between universities, hospitals, SMEs and large companies within the healthcare discipline in the region.
Last updated on: 27/08/2010